Profiel
Christopher Thorn worked as the Chief Financial Officer at Humanigen, Inc. in 2015 and as a Controller at Vyera Pharmaceuticals LLC.
He received an undergraduate degree and an MBA from St. John's University.
Eerdere bekende functies van Christopher Thorn
| Bedrijven | Functie | Einde |
|---|---|---|
| HUMANIGEN, INC. | Financieel Directeur/CFO | 21-12-2015 |
Vyera Pharmaceuticals LLC
 Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | - |
Opleiding van Christopher Thorn
| St. John's University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Vyera Pharmaceuticals LLC
Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Health Technology |
